Denali Therapeutics Inc (NAS:DNLI)
$ 18.31 -0.36 (-1.93%) Market Cap: 2.61 Bil Enterprise Value: 1.78 Bil PE Ratio: 0 PB Ratio: 1.83 GF Score: 62/100

Denali Therapeutics Inc (DNLI) Transcripts

  • 1